Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAROTRECTINIB vs LATUDA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAROTRECTINIB vs LATUDA: Safety Overview

Metric LAROTRECTINIB LATUDA
Total FAERS Reports 798 130
Deaths Reported 149 10
Death Rate 18.7% 7.7%
Hospitalizations 151 42
Average Patient Age 48.9 yrs 42.5 yrs
% Female Patients 51.5% N/A
FDA Approval Date Nov 26, 2018 N/A
Manufacturer Bayer HealthCare Pharmaceuticals Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A